Gilead Sciences to Present at the UBS 2015 Global Healthcare Conference on Tuesday, May 19
19 May 2015 - 7:00AM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its
corporate presentation will be webcast from the UBS 2015 Global
Healthcare Conference in New York.
Robin Washington, Gilead’s Executive Vice President and Chief
Financial Officer, will provide an overview of the company at the
conference on Tuesday, May 19 at 10:00 a.m. Eastern Time.
The live webcast of the call can be accessed at the company’s
Investors page at www.gilead.com/investors. Please connect to the
company’s website at least 15 minutes prior to the start of the
call to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150518006570/en/
Gilead Sciences, Inc.Patrick O’Brien, 650-522-1936Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2024 to May 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2023 to May 2024